Newsletters
Maintaining Privilege in AI-assisted Internal Investigations
01.09.2026
Newsletters
01.09.2026
Newsflashes
20.08.2026
Deals & Cases
25.08.2026
Schellenberg Wittmer advised Boehringer Ingelheim, one of the largest pharmaceutical companies, on the acquisition of Evax AG. Evax AG is a Swiss biotech company focused on equine health.
Newsflashes
19.08.2026
Newsletters
01.09.2026
Arbitration Case Alert
20.08.2026
Newsflashes
19.08.2026
Deals & Cases
25.08.2026
Schellenberg Wittmer advised Boehringer Ingelheim, one of the largest pharmaceutical companies, on the acquisition of Evax AG. Evax AG is a Swiss biotech company focused on equine health.
Newsflashes
20.08.2026
Newsflashes
19.08.2026
Newsletters
01.09.2026
Deals & Cases
25.08.2026
Schellenberg Wittmer advised Boehringer Ingelheim, one of the largest pharmaceutical companies, on the acquisition of Evax AG. Evax AG is a Swiss biotech company focused on equine health.
Arbitration Case Alert
20.08.2026
Newsflashes
20.08.2026
Newsflashes
19.08.2026
Newsflashes
19.08.2026